I was diagnosed with PCL in Jan 23 and began isatuximab (S), VRD and was in remission in 4-5 months, followed by and SCT last September. MRD two months later was negative. However, due to high risk disease (78% plasma cells in blood and 3 markers at diagnosis), my specialist thought it best to resume SVR (no dex thankfully). I have remained in remission but I think the Velcade is affecting my kidneys. I had renal insufficiency at diagnosis which markedly improved. After stopping Velcade et all prior to the SCT, my renal function normalized and stayed that way until after beginning maintenance therapy. I had severe GI SE from the Velcade (constipation) and finally my team agreed to cut the dose in half. Much improved, though my renal function is still off with an estimated GFR in the 50's.
My question is, if you have achieved remission or close to it, what is your maintenance therapy? My team is understandably worried that PCL will relapse but I am wondering if I can risk stopping the Velcade. I know Kyprolis is an alternative but it can affect the heart, so given my history, I would chose renal damage over heart.
I know this is an impossible question as so little is known about PCL. I suppose in the long run, I can stay with it as long as my kidneys don't get worse. Thanks and good cheer to all.
Deborah